Fjarde AP Fonden Fourth Swedish National Pension Fund Boosts Stock Position in HCA Healthcare, Inc. $HCA

Fjarde AP Fonden Fourth Swedish National Pension Fund increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 59.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 67,539 shares of the company’s stock after purchasing an additional 25,070 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in HCA Healthcare were worth $31,962,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp increased its stake in shares of HCA Healthcare by 1.0% in the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after acquiring an additional 76,039 shares during the period. Capital World Investors boosted its holdings in HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock valued at $2,334,040,000 after purchasing an additional 40,086 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of HCA Healthcare by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock valued at $1,702,738,000 after buying an additional 13,565 shares during the last quarter. Norges Bank purchased a new stake in shares of HCA Healthcare in the fourth quarter worth about $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership raised its position in HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock valued at $1,078,966,000 after acquiring an additional 245,887 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on HCA shares. Oppenheimer dropped their price objective on shares of HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Robert W. Baird dropped their price target on shares of HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. KeyCorp decreased their price objective on shares of HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Sanford C. Bernstein cut their price target on HCA Healthcare from $503.00 to $413.00 and set a “market perform” rating for the company in a research note on Thursday, June 4th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating on the stock in a research report on Tuesday, April 28th. Fifteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $503.00.

HCA Healthcare Stock Up 4.3%

HCA opened at $409.99 on Friday. HCA Healthcare, Inc. has a twelve month low of $330.00 and a twelve month high of $556.52. The company has a market cap of $90.95 billion, a PE ratio of 14.10, a price-to-earnings-growth ratio of 1.25 and a beta of 1.12. The company has a 50-day moving average price of $401.89 and a 200 day moving average price of $462.80.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same period in the previous year, the company earned $6.45 EPS. HCA Healthcare’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th were paid a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.